Actively Recruiting
Register for Pediatric Patients With Antiphospholipid Syndrome (APS): European Project Extended Internationally Study
Led by University of California, Davis · Updated on 2025-12-05
50
Participants Needed
1
Research Sites
1739 weeks
Total Duration
On this page
Sponsors
U
University of California, Davis
Lead Sponsor
M
Ministry of Higher Education, Science and Technology, Solvenia
Collaborating Sponsor
AI-Summary
What this Trial Is About
The purpose of this study is to gather information about causes and treatment of Antiphospholipid Syndrome.
CONDITIONS
Official Title
Register for Pediatric Patients With Antiphospholipid Syndrome (APS): European Project Extended Internationally Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- 18 years of age or younger at the onset of disease
- Presence of vascular thrombosis
- UC Davis patient
- Presence of at least one laboratory criteria including: anticardiolipin antibody, anti-B glycoprotein-I antibody, or lupus anticoagulant in plasma
You will not qualify if you...
- Infants born to mothers with Antiphospholipid Syndrome
- Infants with congenital thrombophilia
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
UC Davis Medical Center
Sacramento, California, United States, 95817
Actively Recruiting
Research Team
L
Lavjay Butani
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here